Molina Healthcare (MOH)
NYSE: MOH · Healthcare Plans · Long Beach, CA
Our rating: Cautious
Cautious reaffirmed at $209.15, moderate conviction, October 23, 2026.
Breaks if: The cautious view is wrong if Molina's free cash flow recovers to a positive figure above $350 million in each of the next two consecutive quarterly filings (Q4 2026 and Q1 2027), demonstrating that the more than $1.1 billion earnings-to-cash gap in the current period was a timing anomaly rather than a structural claims deterioration. On the price side, the call is also wrong if MOH trades above $252 within the next twelve months without any corresponding improvement in the cash picture, which would imply the market has visibility into claim trends or contract wins that the current filings do not yet reflect.
Key figures
| Market value | $10.4B |
|---|---|
| Revenue, last 12 months | $44.1B |
| Net income, last 12 months | −$48M |
| Free cash flow, last 12 months | $238M |
| Price to earnings | n/a |
| Free cash flow yield | 2.3% |
| Dividend yield | 0.0% |
| Operating margin | 0.4% |
| Return on equity | −1.2% |
| Beta to the S&P 500 | 0.12 |
| Volatility, annualized | 51.4% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $11.1B | −3.4% | $0.73 | −$196M |
| June 30, 2026 | $10.9B | −4.8% | $1.19 | −$324M |
| March 31, 2026 | $10.8B | −3.1% | $0.27 | $1.1B |
| December 31, 2025 | $11.4B | 8.3% | $-2.87 | −$297M |
| September 30, 2025 | $11.5B | 11.0% | $1.51 | −$163M |
| June 30, 2025 | $11.4B | 15.7% | $4.75 | −$344M |
| March 31, 2025 | $11.1B | 12.2% | $5.45 | $168M |
| December 31, 2024 | $10.5B | 16.0% | $4.45 | −$235M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $11.3B: Claude 42%, Gemini 20%, Mistral 30%
- Diluted earnings per share are above zero: Claude 72%, Gemini 90%, Mistral 75%
- Free cash flow for the quarter is above zero: Claude 45%, Gemini 15%, Mistral 20%
14 ledger entries and 56 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.